Geneva, May 4 -- International Clinical Trials Registry received information related to the study (DRKS00040007) titled 'Implementation of 3D-printed pharmaceuticals in geriatric/neurological care concepts: opportunities, barriers and perspectives' on April 23.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: other
Primary Sponsor: Helios Klinikum Erfurt GmbH
Condition:
R13
G20
G21
Dysphagia
Parkinson disease
Secondary parkinsonism
Intervention:
Group 1: Observational study: Questionnaire taken after taking the 3D-printed tablet compared to a standard tablet
Repeated intake/one-time questionnaire survey
Recruitment Status: Not Recruiting
Date of First Enrollment: 01/05/2...